CC Wealth Ltd continues to track the success of Glenmark Pharmaceuticals Ltd as the Indian company prepares to enter the biologic drug market in Europe and the U.S as early as 2017.
Data3s today announced that Glenmark Pharmaceuticals Sp. z o.o., the Polish division of Glenmark Pharmaceuticals Ltd. (GPL), has signed a 5-year agreement with Data3s for eluzzion CRM